Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

Task Force for the management of COVID-19 of the European Society of Cardiology

doi:https://doi.org/10.1093/eurheartj/ehab866

Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

Task Force for the management of COVID-19 of the European Society of Cardiology

Research output: Contribution to journal › Comment/Letter to the editor › Academic

7 Citations (Scopus)

Original language	English
Pages (from-to)	1776
Number of pages	1
Journal	European Heart journal
Volume	43
Issue number	18
DOIs	https://doi.org/10.1093/eurheartj/ehab866
Publication status	Published - 7 May 2022

Access to Document

https://doi.org/10.1093/eurheartj/ehab866

Cite this

Task Force for the management of COVID-19 of the European Society of Cardiology (2022). Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. European Heart journal, 43(18), 1776. https://doi.org/10.1093/eurheartj/ehab866

Task Force for the management of COVID-19 of the European Society of Cardiology. / Corrigendum to : European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. In: European Heart journal. 2022 ; Vol. 43, No. 18. pp. 1776.

@article{58d17804d1d545e7b1065cc20ddfe935,

title = "Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up",

author = "{Task Force for the management of COVID-19 of the European Society of Cardiology} and Wilde, {Arthur A.M.}",

note = "Correction on Eur Heart J 2022;43(11):1033-1058. https://doi.org/10.1093/eurheartj/ehab696",

year = "2022",

month = may,

day = "7",

doi = "https://doi.org/10.1093/eurheartj/ehab866",

language = "English",

volume = "43",

pages = "1776",

journal = "European Heart journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "18",

}

Task Force for the management of COVID-19 of the European Society of Cardiology 2022, 'Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up', European Heart journal, vol. 43, no. 18, pp. 1776. https://doi.org/10.1093/eurheartj/ehab866

Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. / Task Force for the management of COVID-19 of the European Society of Cardiology.
In: European Heart journal, Vol. 43, No. 18, 07.05.2022, p. 1776.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Corrigendum to

T2 - European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

AU - Task Force for the management of COVID-19 of the European Society of Cardiology

AU - Wilde, Arthur A.M.

N1 - Correction on Eur Heart J 2022;43(11):1033-1058. https://doi.org/10.1093/eurheartj/ehab696

PY - 2022/5/7

Y1 - 2022/5/7

UR - http://www.scopus.com/inward/record.url?scp=85134436549&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/eurheartj/ehab866

DO - https://doi.org/10.1093/eurheartj/ehab866

M3 - Comment/Letter to the editor

C2 - 34927669

SN - 0195-668X

VL - 43

SP - 1776

JO - European Heart journal

JF - European Heart journal

IS - 18

ER -

Task Force for the management of COVID-19 of the European Society of Cardiology. Corrigendum to: European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis; and ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. European Heart journal. 2022 May 7;43(18):1776. doi: https://doi.org/10.1093/eurheartj/ehab866

Access to Document

Other files and links

Cite this